Graft Patency of QFR-guided Versus Angio-guided Coronary Artery Bypass Grafting
NCT ID: NCT03770520
Last Updated: 2018-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
208 participants
INTERVENTIONAL
2017-02-01
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
QFR-guided
This group will be performed a CABG surgery based on CAG and QFR, whether graft the moderate stenosis vessels will be based on the result of QFR.
QFR-guided CABG
CABG surgery based on CAG and QFR
Angio-guided
This group will be performed a CABG surgery only based on CAG, the final surgery strategy will be decided after the discussion of heart team.
Angio-guided CABG
CABG surgery based on heart team discussion of CAG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QFR-guided CABG
CABG surgery based on CAG and QFR
Angio-guided CABG
CABG surgery based on heart team discussion of CAG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* left main or three vessels disease, have the indication for CABG after discussion of the heart team
* at least one main vessels stenosis on 40%-70%
Exclusion Criteria
* need to perform other cardiac or major surgery( i.e. valve surgery, carotid endarterectomy
* emergent CABG
* acute myocardial infarction time less than 7 days
* life expectancy less than 3 years
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Municipal Science & Technology Commission
OTHER
Beijing Anzhen Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Ran
Direcotr,chief of ward No.11, Department of cardiac surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ran Dong, MD
Role: STUDY_DIRECTOR
Beijing Anzhen Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yang Zhao, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Z171100001017059
Identifier Type: -
Identifier Source: org_study_id